AUTL:NSD-Autolus Therapeutics Ltd (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 6.24

Change

+0.07 (+1.13)%

Market Cap

USD 1.64B

Volume

0.41M

Analyst Target

USD 26.33
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

-0.22 (-0.06%)

USD 107.38B
REGN Regeneron Pharmaceuticals Inc

-7.48 (-0.84%)

USD 106.98B
MRNA Moderna Inc

+1.79 (+1.69%)

USD 38.83B
ARGX argenx NV ADR

+4.20 (+1.14%)

USD 22.08B
BNTX BioNTech SE

+0.50 (+0.58%)

USD 21.93B
GMAB Genmab AS

+0.69 (+2.51%)

USD 19.78B
ALNY Alnylam Pharmaceuticals Inc

-0.40 (-0.28%)

USD 18.18B
RPRX Royalty Pharma Plc

-0.11 (-0.39%)

USD 18.18B
BGNE BeiGene Ltd

+5.02 (+3.38%)

USD 16.99B
BMRN Biomarin Pharmaceutical Inc

-1.26 (-1.53%)

USD 16.06B

ETFs Containing AUTL

HOML 8.77 % 0.00 %

N/A

N/A
CLAW 6.09 % 0.95 %

N/A

N/A
ITB 3.91 % 0.42 %

N/A

N/A
PEZ Invesco DWA Consumer Cycl.. 3.82 % 0.60 %

+1.89 (+0.72%)

USD 0.06B
NAIL Direxion Daily Homebuilde.. 2.77 % 0.99 %

+3.65 (+0.72%)

USD 0.24B
TQSM:CA TD Q U.S. Small-Mid-Cap E.. 2.13 % 0.00 %

+0.11 (+0.72%)

CAD 0.19B
ZEUS:CA 1.40 % 0.73 %

N/A

N/A
VAMO 1.34 % 0.64 %

N/A

N/A
FSMD Fidelity Small-Mid Factor 0.34 % 0.00 %

+0.09 (+0.72%)

USD 0.21B
JKJ iShares Morningstar Small.. 0.31 % 0.25 %

N/A

USD 0.21B
ISCB iShares Morningstar Small.. 0.30 % 0.00 %

+0.38 (+0.72%)

USD 0.21B
WDSC:LSE SPDR MSCI World Small Cap.. 0.19 % 0.00 %

+1.04 (+0.72%)

USD 0.83B
WOSC:LSE SPDR MSCI World Small Cap.. 0.19 % 0.00 %

+0.97 (+0.72%)

USD 0.83B
ZPRS:F SSgA SPDR ETFs Europe II .. 0.19 % 0.00 %

+1.32 (+0.72%)

USD 0.83B
ZPRS:XETRA SPDR MSCI World Small Cap.. 0.19 % 0.00 %

+1.16 (+0.72%)

USD 0.83B
WLDS:LSE iShares MSCI World Small .. 0.18 % 0.00 %

+0.07 (+0.72%)

USD 3.61B
WSML:LSE iShares MSCI World Small .. 0.18 % 0.00 %

+0.07 (+0.72%)

USD 3.61B
IUSN:F iShares MSCI World Small .. 0.17 % 0.00 %

+0.09 (+0.72%)

USD 3.82B
IUSN:XETRA iShares MSCI World Small .. 0.17 % 0.00 %

+0.09 (+0.72%)

USD 3.82B
CNCR Loncar Cancer Immunothera.. 0.00 % 0.79 %

+0.44 (+0.72%)

USD 0.02B
FNK First Trust Mid Cap Value.. 0.00 % 0.70 %

+0.10 (+0.72%)

USD 0.23B
XHB SPDR® S&P Homebuilders E.. 0.00 % 0.35 %

+1.25 (+0.72%)

USD 2.01B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.11% 44% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.11% 44% F 39% F
Trailing 12 Months  
Capital Gain 246.67% 96% N/A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 246.67% 96% N/A 98% N/A
Trailing 5 Years  
Capital Gain -80.17% 38% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -80.17% 38% F 14% F
Average Annual (5 Year Horizon)  
Capital Gain -13.31% 43% F 24% F
Dividend Return -13.31% 43% F 24% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 70.97% 39% F 22% F
Risk Adjusted Return -18.76% 47% F 32% F
Market Capitalization 1.64B 86% B+ 78% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector